GSA Capital Partners’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-29,094
Closed -$458K 2019
2022
Q2
$458K Buy
29,094
+7,262
+33% +$111K 0.07% 556
2022
Q1
$332K Sell
21,832
-27,411
-56% -$417K 0.04% 824
2021
Q4
$757K Buy
+49,243
New +$648K 0.1% 346
2021
Q1
Sell
-44,146
Closed -$401K 1626
2020
Q4
$401K Buy
44,146
+2,768
+7% +$21.4K 0.07% 569
2020
Q3
$252K Buy
41,378
+15,230
+58% +$116K 0.04% 862
2020
Q2
$232K Sell
26,148
-38,750
-60% -$334K 0.13% 273
2020
Q1
$471K Buy
64,898
+42,105
+185% +$312K 0.12% 199
2019
Q4
$201K Sell
22,793
-9,446
-29% -$70.7K 0.02% 1260
2019
Q3
$196K Sell
32,239
-14,686
-31% -$82.5K 0.03% 1173
2019
Q2
$196K Buy
+46,925
New +$247K 0.02% 1244
2019
Q1
Sell
-35,397
Closed -$229K 1774
2018
Q4
$229K Buy
+35,397
New +$271K 0.03% 1016
2017
Q2
Sell
-166,769
Closed -$1.5M 2035
2017
Q1
$1.5M Buy
+166,769
New +$1.74M 0.08% 411
2016
Q4
Sell
-63,311
Closed -$1.03M 2029
2016
Q3
$1.03M Buy
63,311
+5,394
+9% +$75.9K 0.06% 590
2016
Q2
$552K Buy
57,917
+45,117
+352% +$491K 0.03% 1007
2016
Q1
$180K Sell
12,800
-16,882
-57% -$175K 0.01% 1511
2015
Q4
$322K Buy
+29,682
New +$268K 0.02% 1423
2015
Q3
Sell
-48,480
Closed -$443K 2103
2015
Q2
$443K Buy
48,480
+35,680
+279% +$270K 0.02% 1422
2015
Q1
$86K Buy
+12,800
New +$51.5K ﹤0.01% 2032
2013
Q4
Sell
-20,312
Closed -$150K 1808
2013
Q3
$150K Sell
20,312
-2,000
-9% -$15.6K 0.01% 1453
2013
Q2
$194K Buy
+22,312
New +$143K 0.02% 1103

Other funds holding NPTN

GSA Capital Partners's NPTN Position: Q3 2022 in Review

GSA Capital Partners sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 29,094 shares — an estimated $458K sold.

GSA Capital Partners first reported a position in NPTN in Q2 2013 and held it in 20 quarters. The position peaked at $1.5M in Q1 2017. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • GSA Capital Partners reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • GSA Capital Partners sold 29,094 NEOPHOTONICS CORP shares in Q3 2022, an estimated $458K.
  • GSA Capital Partners first reported a position in NEOPHOTONICS CORP in Q2 2013 and held it in 20 quarters.
  • GSA Capital Partners's NEOPHOTONICS CORP position peaked at $1.5M in Q1 2017.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.